Discounted Cash Flow
Biolife Solutions Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $8.2m | $-6.9m | $-4.5m | -83.6% | $-0.54 |
| 2017 | $11.0m (34.0%) | $-2.5m (63.4%) | $461.4k (110.3%) | -22.8% (72.7%) | $-0.21 (61.1%) |
| 2018 | $19.7m (79.1%) | $3.3m (229.9%) | $1.8m (300.6%) | 16.5% (172.5%) | $0.18 (185.7%) |
| 2019 | $27.4m (38.6%) | $-1.7m (-150.7%) | $538.0k (-70.9%) | -6.1% (-136.6%) | $-0.09 (-150.0%) |
| 2020 | $48.1m (75.7%) | $2.7m (261.0%) | $4.7m (770.6%) | 5.5% (191.6%) | $0.09 (200.0%) |
| 2021 | $119.2m (147.8%) | $-7.6m (-386.3%) | $-13.0m (-377.1%) | -6.4% (-215.5%) | $-0.20 (-322.2%) |
| 2022 | $161.8m (35.8%) | $-139.8m (-1731.1%) | $-18.9m (-45.4%) | -86.4% (-1248.8%) | $-3.29 (-1545.0%) |
| 2023 | $143.3m (-11.4%) | $-66.4m (52.5%) | $-18.9m (-0.0%) | -46.4% (46.4%) | $-1.52 (53.8%) |
| 2024 | $82.3m (-42.6%) | $-20.2m (69.6%) | $5.2m (127.6%) | -24.5% (47.1%) | $-0.44 (71.1%) |
| 2025 | $96.2m (17.0%) | $-4.6m (77.2%) | $10.6m (104.4%) | -4.8% (80.5%) | $-0.09 (79.5%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.